494 related articles for article (PubMed ID: 36071285)
1. Advances in the management of peritoneal malignancies.
Kepenekian V; Bhatt A; Péron J; Alyami M; Benzerdjeb N; Bakrin N; Falandry C; Passot G; Rousset P; Glehen O
Nat Rev Clin Oncol; 2022 Nov; 19(11):698-718. PubMed ID: 36071285
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
[TBL] [Abstract][Full Text] [Related]
3. Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
López-Basave HN; Quiroz-Sandoval OA; Padilla-Rosciano AE; León-Takahashi AM; Miranda-Devora G; Arrollo-Monroy A
Cir Cir; 2018; 86(3):277-284. PubMed ID: 29950734
[TBL] [Abstract][Full Text] [Related]
4. [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].
Iesalnieks I; Kullmann F; Dahlke M; Ghali N; Agha A; von Breitenbuch P; Schoelmerich J; Schlitt HJ; Piso P
Z Gastroenterol; 2006 Dec; 44(12):1237-45. PubMed ID: 17163375
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal cancer treatment.
Yonemura Y; Canbay E; Endou Y; Ishibashi H; Mizumoto A; Miura M; Li Y; Liu Y; Takeshita K; Ichinose M; Takao N; Hirano M; Sako S; Tsukiyama G
Expert Opin Pharmacother; 2014 Apr; 15(5):623-36. PubMed ID: 24617975
[TBL] [Abstract][Full Text] [Related]
6. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
[TBL] [Abstract][Full Text] [Related]
7. Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
Leigh N; Solomon D; Pletcher E; Labow DM; Magge DR; Sarpel U; Golas BJ
World J Surg Oncol; 2020 Jun; 18(1):124. PubMed ID: 32527272
[TBL] [Abstract][Full Text] [Related]
8. [Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia].
Gómez Portilla A; Cendoya I; Muriel J; Olabarria I; Guede N; Moraza N; Fernández E; Martínez de Lecea C; Magrach L; Martín E; Romero E; Aguado I; Valdovinos M; Larrabide I
Cir Esp; 2007 Feb; 81(2):82-6. PubMed ID: 17306123
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
10. Primary and metastatic peritoneal surface malignancies.
Cortés-Guiral D; Hübner M; Alyami M; Bhatt A; Ceelen W; Glehen O; Lordick F; Ramsay R; Sgarbura O; Van Der Speeten K; Turaga KK; Chand M
Nat Rev Dis Primers; 2021 Dec; 7(1):91. PubMed ID: 34916522
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal vascular endothelial growth factor burden in peritoneal surface malignancies treated with curative intent: the first step before intraperitoneal anti-vascular endothelial growth factor treatment?
Passot G; Bakrin N; Garnier L; Roux A; Vaudoyer D; Wallet F; Gilly FN; Glehen O; Cotte E
Eur J Cancer; 2014 Mar; 50(4):722-30. PubMed ID: 24295636
[TBL] [Abstract][Full Text] [Related]
12. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
[TBL] [Abstract][Full Text] [Related]
13. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer].
Gronau F; Jara M; Feldbrügge L; Wolf V; Oeff A; Rau B
Chirurg; 2021 Jun; 92(6):522-527. PubMed ID: 33620502
[TBL] [Abstract][Full Text] [Related]
14. Advances with pharmacotherapy for peritoneal metastasis.
Yonemura Y; Iahibashi H; Sako S; Mizumoto A; Takao N; Ichinose M; Motoi S; Liu Y; Wakama S; Kamada Y; Nishihara K
Expert Opin Pharmacother; 2020 Nov; 21(16):2057-2066. PubMed ID: 32783786
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
[TBL] [Abstract][Full Text] [Related]
16. Imaging of pre- and post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pediatric intraperitoneal malignancy.
Hull NC; Granberg CF; Gargollo PC; Thacker PG
Pediatr Radiol; 2022 Nov; 52(12):2254-2266. PubMed ID: 36207454
[TBL] [Abstract][Full Text] [Related]
17. Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
Baratti D; Kusamura S; Azmi N; Guaglio M; Montenovo M; Deraco M
Ann Surg Oncol; 2020 Jan; 27(1):98-106. PubMed ID: 31691116
[TBL] [Abstract][Full Text] [Related]
18. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
Paul BK; Ihemelandu C; Sugarbaker PH
Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
[TBL] [Abstract][Full Text] [Related]
19. Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies.
Klos D; Riško J; Stašek M; Loveček M; Hanuliak J; Skalický P; Lemstrová R; Mohelníková BD; Študentová H; Neoral Č; Melichar B
Cas Lek Cesk; 2018 Dec; 157(8):419-428. PubMed ID: 30754979
[TBL] [Abstract][Full Text] [Related]
20. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies.
Li Y; Zhou YF; Liang H; Wang HQ; Hao JH; Zhu ZG; Wan DS; Qin LX; Cui SZ; Ji JF; Xu HM; Wei SZ; Xu HB; Suo T; Yang SJ; Xie CH; Yang XJ; Yang GL
World J Gastroenterol; 2016 Aug; 22(30):6906-16. PubMed ID: 27570426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
